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A single nucleotide substitution in the third intron of insulin-like
growth factor 2 (IGF2) is associated with increased muscle mass
and reduced subcutaneous fat in domestic pigs. This mutation dis-
rupts the binding of the ZBED6 transcription factor and leads to a
threefold up-regulation of IGF2 expression in pig skeletal muscle.
Here, we investigated the biological significance of ZBED6–IGF2 in-
teraction in the growth of placental mammals using two mouse
models, ZBED6 knock-out (Zbed6−/−) and Igf2 knock-in mice that
carry the pig IGF2mutation. These transgenic mice exhibit markedly
higher serum IGF2 concentrations, higher growth rate, increased
lean mass, and larger heart, kidney, and liver; no significant changes
were observed for white adipose tissues. The changes in body and
lean mass were most pronounced in female mice. The phenotypic
changes were concomitant with a remarkable up-regulation of Igf2
expression in adult tissues. Transcriptome analysis of skeletal mus-
cle identified differential expression of genes belonging to the ex-
tracellular region category. Expression analysis using fetal muscles
indicated a minor role of ZBED6 in regulating Igf2 expression pre-
natally. Furthermore, transcriptome analysis of the adult skeletal
muscle revealed that this elevated expression of Igf2 was derived
from the P1 and P2 promoters. The results revealed very similar
phenotypic effects in the Zbed6 knock-out mouse and in the Igf2
knock-in mouse, showing that the effect of ZBED6 on growth of
muscle and internal organs is mediated through the binding site in
the Igf2 gene. The results explain why this ZBED6 binding site is
extremely well conserved among placental mammals.
ZBED6 | IGF2 | mouse | muscle growth | metabolic regulation
Insulin-like growth factor 2 (IGF2) was discovered as a growth-promoting factor in the 1970s (1–3). Since that time, IGF2 has
been subjected to intensive studies to understand its biological
role in growth and development and to reveal how IGF2 ex-
pression is regulated in different tissues and developmental
stages. IGF2 is a maternally imprinted gene normally expressed
only from the paternal allele (4, 5), with the expression being
derived from multiple promoters. For instance, human IGF2 is
regulated by four promoters (P1–P4), whereas mouse Igf2 is
under the control of three promoters (P1–P3) (6). During the
development of human embryos, expression of IGF2 is mainly
arising from the fetal-specific promoters P2–P4. After birth,
expression of IGF2 is dramatically reduced, and in adult tis-
sues, only low expression, mainly from the P1 promoter, is
found (7).
ZBED6 was discovered as a transcriptional repressor of IGF2
subsequent to the discovery that a single base change in IGF2
intron 3 in pigs is causing a major quantitative trait locus af-
fecting muscle growth, size of the heart, and fat deposition (8, 9).
The mutation disrupts a ZBED6 binding site that is extremely
well conserved among placental mammals, and results in a
threefold up-regulation of IGF2 expression in pig skeletal mus-
cle. A single-nucleotide substitution in the binding site (G > A)
in domestic pigs was associated with threefold increase in IGF2
mRNA in skeletal muscle and resulted in increased muscle mass
and heart size and reduced subcutaneous fat mass (8). The im-
portance of this ZBED6 binding site for regulating IGF2 mRNA
expression has been documented in several human and murine
cell lines (9–12). Furthermore, ChIP-seq analysis has demon-
strated that ZBED6 binds, in addition to the IGF2 site, thou-
sands of sites in the human and murine genomes. In the present
study, we established both a Zbed6 knock-out (Zbed6−/−) and
an Igf2 knock-in (Igf2G/A) mouse, the latter carrying the same
mutation as previously described in pigs, to investigate the
physiological importance of the ZBED6–IGF2 axis. This exper-
imental design allowed us to investigate which phenotypic effects
caused by Zbed6 inactivation are mediated through its in-
teraction with the binding site in the Igf2 gene.
Significance
Insulin-like growth factor 2 (IGF2) is an important growth fac-
tor with a critical role for fetal growth in mammals. The
ZBED6 transcription factor is unique to placental mammals and
has evolved from a domesticated DNA transposon. This study
shows that ZBED6 and its interaction with the Igf2 locus play a
prominent role in regulating postnatal growth of skeletal
muscle and internal organs (kidney, liver, and heart) in pla-
cental mammals. This prominent role in mammalian biology
provides a reasonable explanation why ZBED6 is highly con-
served among all families of placental mammals and why
16 base pairs encompassing the ZBED6 binding site in an intron
of Igf2 are conserved among the great majority of, if not all,
placental mammals.
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Results
Establishment of Zbed6 Knock-Out and Igf2 Knock-In Transgenic Mice.
ZBED6 is encoded by an intronless gene located in the first
intron of the Zc3h11a gene. The conditional Zbed6 knock-out
mouse was generated by inserting loxP sites flanking the coding
sequence of Zbed6, using homologous recombination (Fig. 1A).
These mice were crossed with mice expressing Cre in germ-line
(PGK-Cre), which resulted in deletion of Zbed6 in all tissues.
The Igf2 allele (Igf2A) was generated by introducing a single-
nucleotide substitution of G to A by homologous recombina-
tion at the ZBED6 binding site GGCTCG in the first intron of
Igf2, which is identical to the regulatory mutation in the domestic
pig (8) (Fig. 1B). The aim of the experimental design was to only
compare wild-type Igf2G/G homozygotes with Igf2pA/mG hetero-
zygotes (p = paternal, m = maternal), because it is well estab-
lished that Igf2 is paternally expressed in mice. The intercross
between Zbed6 knock-out and Igf2 knock-in mice was established
by crossing male mice heterozygous at both Zbed6 and Igf2
(_ Zbed6+/−, Igf2A/G) with females that were heterozygous at
Zbed6 and homozygous wild-type at Igf2 (\ Zbed6+/−, Igf2G/G) to
obtain paternal expression of the Igf2 mutation in 50% of the
offspring. Littermates representing four of the six genotype
classes were used in the phenotypic characterization and down-
stream analysis; the Zbed6+/− mice were only used in the expres-
sion analysis of fetal tissue. The following abbreviations are used in
the figures to represent the four genotypes: WT-G = Zbed6+/+,
Igf2G/G; WT-G/A = Zbed6+/+, Igf2pA/mG; KO-G = Zbed6−/−, Igf2G/G;
and KO-G/A = Zbed6−/−, Igf2pA/mG.
Disruption of ZBED6–IGF2 Interaction Resulted in Increased Circulating
Levels of IGF2 and Increased Growth. Serum IGF2 levels were about
eightfold higher in Zbed6 knock-out and Igf2 knock-in mice com-
pared with wild-type littermates (Fig. 1C). In wild-type mice, levels
ranged between 1.2 and 3.2 ng/mL, whereas levels were >10 ng/mL
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in all three mutant genotype groups. There was no significant
difference in IGF2 serum levels among the three mutant
genotypes.
Both the Zbed6 knock-out and Igf2 knock-in mice showed
increased body weight, around 20% in Igf2pA/mG and 15% in
Zbed6−/− females and 14% in Igf2pA/mG and 4% in Zbed6−/−
males at the age of 20 wk (Fig. 2A). Thus, the increased growth
rate was most pronounced in the Zbed6 wild-type, Igf2 mutant
mice (Fig. 2A). After 20 wk of age, the mice were transferred to a
facility in which quantitative measurements of whole-body
composition were performed using an EchoMRI system at
23 wk of age. At this age, the difference in body weight between
wild-type and mutant mice was only significant in females (Fig.
2B). In fact, there appears to be a trend in males in which higher
body weights in Zbed6−/− mice at early age (Fig. 2A) disappear
over time and are absent at 23 wk of age (Fig. 2B). EchoMRI
revealed an increased lean body mass in female Igf2pA/mG and
Zbed6−/− mice (Fig. 2B). Inactivating Zbed6 or paternal ex-
pression of the mutant Igf2 allele had very similar effects on lean
body mass (Fig. 2B).
We further characterized the effects of the ZBED6–Igf2 in-
teraction on lean body mass by individual dissection of four
skeletal muscle types (gastro-gastrocnemius, soleus, tibialis an-
terior, and extensor digitorum longus). All muscle types were
significantly increased in size in females for all three mutant
genotype groups (Fig. 3A), whereas in males, the difference
between genotypes was minor and only reached statistical sig-
nificance in Zbed6 wild-type-Igf2 knock-in males (Fig. 3B). In
contrast, quantitative PCR (qPCR) analysis of cDNA from tibialis
anterior muscle showed a very similar marked up-regulation of Igf2
mRNA in males and females and across the three mutant geno-
types (Fig. 3C). The up-regulation of Igf2 expression in the Igf2pA/mG
Zbed6−/− double-mutant mice was very similar to that observed in
the Igf2pA/mG or Zbed6−/− single-mutant mice. This indicates that
there is no additive effect in Igf2 up-regulation by disrupting Zbed6
and by deleting the ZBED6 binding site in Igf2.
Mild Metabolic Changes in Zbed6−/− Mice. Respiratory exchange
ratios (RERs) were measured during 2 consecutive days and
nights in metabolic cages. This revealed an overall increased
reliance on carbohydrates, rather than lipids, as a fuel source for
male Zbed6−/−mice, with higher RER values than Zbed6+/+mice
during both day and night (Fig. 3D). A corresponding difference
was not noted for female mice (Fig. 3D). The assessment of
whole-body glucose tolerance showed that deletion of Zbed6 or
the IGF2 mutation had no effect on overall glucose tolerance in
males or females (Fig. 3 E and F). However, male Zbed6−/− mice
achieved the same glucose clearance from the blood, with sig-
nificantly reduced plasma insulin levels, indicating increased
whole-body insulin sensitivity (Fig. 3F).
Up-Regulation of Igf2 Expression Promotes the Growth of Internal
Organs. The weights of internal organs (kidney, heart, and
liver) were higher in Zbed6−/− and Igf2pA/mG mice compared with
wild-type littermates. This effect was most pronounced for kid-
ney, where a 14–20% increased organ weight was observed for
both females and males of the three types of transgenic mice
(Fig. 4 A and B). Moreover, the heart size tended to be larger for
all three classes of mutant mice, but the trend was only statis-
tically significant (females) or close to significant (males) for
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Zbed6 wild-type–Igf2 knock-in mice (Fig. 4 C and D). The pat-
tern of increased growth was also apparent in liver from females
of all three types of transgenic mice (Fig. 4E), whereas only
Zbed6 wild-type–Igf2 knock-in males showed a tendency for in-
creased liver weight that approached statistical significance. In
contrast to the increased weight of internal organs in Zbed6/Igf2
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mutant mice, no significant changes were observed in the weight
of gonadal white adipose tissue (Fig. 4 G and H). qPCR analysis
revealed a dramatic up-regulation of Igf2 mRNA in kidney of
both Igf2pA/mG and Zbed6−/− mice and in both sexes (Fig. 4I). An
elevation of Igf2 mRNA expression was also documented in
heart (Fig. 4J). In general, the differences in the growth of in-
ternal organs were more pronounced in females than in males,
whereas the up-regulation of Igf2 expression was similar in males
and females.
The ZBED6–Igf2 Axis Has a Major Effect on Transcriptional Regulation
at the Igf2 Locus. Igf2 and the H19 noncoding RNA are imprinted
genes in which Igf2 is expressed from the paternal allele and H19
from the maternal allele. The transcriptional regulation of these
two genes is controlled by several factors. For instance, disrup-
tion of the imprinting control region between Igf2 and H19 leads
to biallelic expression of both Igf2 and H19 (13, 14). Here, we
explored transcriptional changes caused by the disruption of the
ZBED6–Igf2 interaction on the whole transcriptome and on the
Igf2 locus. We conducted whole-transcriptome analysis of mul-
tiple tissues of wild-type, Zbed6−/−, and Igf2pA/mGmice; the double-
mutant mice were not included in this analysis. Around 10 million
sequenced reads per sample were aligned to the mouse reference
genome (mm10), and the uniquely mapped reads were used for
differential expression (DE) analysis, using Cufflinks (15). Zbed6
is located in the first intron of another zinc-finger protein gene
Zc3h11a, and the ZBED6 protein is expressed after intron re-
tention in transcripts containing the entire coding sequence of
this “host” gene (9). However, the RNAseq data indicated that
the expression of Zc3h11a was not affected by Zbed6 inactivation
(Fig. S1).
The visualization of the mapped reads in female skeletal
muscle tissue (tibialis anterior) confirmed a complete knock-out
of Zbed6 expression in Zbed6−/− mice, whereas Zbed6 expression
was not affected in Igf2pA/mG mice as expected (Fig. 5A). In
tibialis anterior muscle of female mice, 108 and 82 DE genes
were identified in Zbed6−/− and Igf2pA/mG mice, respectively,
compared with wild-type mice (P < 0.05 after Benjamini–Hochberg
correction for multiple testing; Fig. 5B), with 42 shared DE genes
between the two groups (Fig. 5C). Igf2 was the most significant DE
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gene in skeletal muscle of both Zbed6−/− and Igf2pA/mG mice, with
more than 20-fold up-regulation (Fig. 5D), in agreement with the
qPCR analysis (Fig. 3C). The Igf2 opposite-strand (Igf2os) tran-
script was also up-regulated 20-fold, whereas no significant changes
were detected for the H19 RNA (Fig. 5D).
A number of genes showed differential expression in Zbed6−/−,
but not in Igf2pA/mG, mice, and vice versa (Fig. 5C). For example,
the expression of the transmembrane protein 8 (Tmem8) and
energy homeostasis-associated (Enho) genes were significantly
up-regulated in skeletal muscle of Zbed6−/−mice, but not Igf2pA/mG
mice (Fig. 5E). Both Tmem8 and Enho were previously identified
as putative direct targets of ZBED6 based on ChIP-seq analysis
(10). ZBED6 is expected to affect transcriptional regulation of
many genes other than Igf2. The significant differences in the
transcriptome between Zbed6−/− and Igf2pA/mGmice, although they
both overexpress Igf2, is consistent with this notion. The gene
ontology analysis of DE genes in skeletal muscle in both Zbed6−/−
and Igf2pA/mG mice revealed a significant enrichment of genes
belonging to the extracellular region category (Dataset S1).
The results of the transcriptome analysis of skeletal muscle
tissue from male mice were in excellent agreement with the results
obtained for female mice (Fig. S2 and Dataset S2). In agreement
with expression analysis of the skeletal muscle tissues of the fe-
males, Igf2 was the most up-regulated gene in both Zbed6−/− and
Igf2pA/mG muscle tissues, whereas Enho and Tmem8 were only up-
regulated in the skeletal muscle of Zbed6−/− mice (Fig. S2).
We also carried out transcriptome analysis of heart and kidney
tissue (SI Text and Figs. S3 and S4). The results were in line with
those obtained for the muscle transcriptome, and the results for
males and females were highly consistent. The numbers of DE
genes per genotype (Zbed6−/− and Igf2pA/mG) were in the range of
26–255. We observed a dramatic increase in Igf2 expression in
both genotypes; in contrast, the putative ZBED6 targets Enho,
Tmem8, and Pianp (paired immunoglobin-like type 2 receptor-
associating neural protein) only showed differential expression be-
tween wild-type and Zbed6−/− mice. Interestingly, Tmem8 showed
highly significant differential expression in heart, but not in kidney,
suggesting tissue-specific ZBED6 regulation (Fig. S3 D and K).
ZBED6 Primarily Regulates Igf2 Expression Postnatally. Igf2 is ex-
pressed at high levels in fetal tissues and is markedly down-
regulated after birth. Our results show that the disruption of
ZBED6–Igf2 interaction leads to a profound up-regulation of
Igf2 expression in multiple organs in adult mice (see previous
section). To investigate the possible role of ZBED6 in regulating
Igf2 expression in fetal tissues, we performed transcriptome
analysis of fetal muscle tissue using Zbed6−/−, Zbed6+/−, and
wild-type embryos at day 12.5. Fifty-seven genes showed signif-
icant differential expression between wild-type and Zbed6−/−
embryos (Fig. 6 A and B). A closer examination of these differ-
entially expressed genes (Fig. S5) shows that as many as 28 (49%)
are associated with a ZBED6 ChIP-seq peak, which is a significant
enrichment, as only 23% of all of the 12,228 genes with a de-
tectable expression in this experiment were associated with a
ChIP-seq peak (P = 0.002; Fisher’s exact test). The result implies
that a large proportion of these 28 genes are direct targets of
ZBED6. Furthermore, 25 of the 28 DE genes associated with a
ChIP-seq peak showed significant up-regulation of expression in
Zbed6−/− mice, consistent with the notion that ZBED6 primarily,
or possibly exclusively, acts as a repressor. In fact, the differential
expression for the three genes showing the opposite trend was not
convincing because of heterogeneity within genotype classes (Fig.
S5). Interestingly, for the majority of these 28 genes, showing DE
between wild-type and Zbed6−/− mice, as well as for the Zbed6
locus itself, the Zbed6+/− heterozygotes showed intermediate ex-
pression indicating that the direct targets of ZBED6 are dose
sensitive for the amount of ZBED6 present (Fig. S5).
In contrast to what we observed in adult tissues, Igf2 showed
only marginally increased expression when ZBED6 was knocked
out in fetal muscle tissue (Fig. 6C). Two other putative direct
targets for ZBED6, Enho and Tmem8, were both significantly
up-regulated in Zbed6−/− embryos (Fig. 6C). The differential
expression of Enho and Tmem8 and other putative direct targets
(Fig. S5) showed that ZBED6 must be functionally active in fetal
tissues, despite the lack of a strong up-regulation of Igf2 ex-
pression. The observed differential expression patterns from
RNA-seq analysis of embryos were validated by qPCR assay,
using fetal muscle and brain tissues. The change in Igf2 mRNA
expression in Zbed6−/− embryos was limited to a 1.2-fold up-regulation
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in fetal muscle tissues, whereas no significant changes were de-
tected in brain tissue (Fig. 6D). In agreement with RNA-seq
data of embryos, the expression of Enho mRNA was up-regulated
threefold in Zbed6−/− and approximately twofold in Zbed6+/− fetal
muscle tissues (Fig. 6E).
A comparison of transcriptome data from fetal and adult skeletal
muscle tissues of wild-type mice demonstrated dramatic changes in
the expression profile of thousands of genes. As expected, Igf2 was
one of the most significantly DE genes between fetal and adult
tissues, with high expression in fetal muscle and low expression in
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adult skeletal muscle (Fig. 6F). An isoform quantification analysis
using Cufflinks revealed that the majority of Igf2 expression in fetal
tissues exists as the NM_010514 isoform, which is mainly initiated
from the P2 promoter (Fig. 6G, Left). Surprisingly, the disruption of
the ZBED6–Igf2 interaction led to increased transcriptional activi-
ties from both the P1 and P2 promoters in adult muscle. The ele-
vated Igf2 expression in Igf2pA/mG and Zbed6−/− muscles was
derived 60% from the NM_010514 isoform and 40% from the
NM_00112273 isoform (Fig. 6G, Right). The results suggest
that ZBED6 acts as a more important repressor at the Igf2
locus in adult tissues than in fetal tissue.
Discussion
The evolution of ZBED6 is an innovation that took place during
the development of placental mammals. The high sequence
conservation of the Zbed6 gene across placental mammals shows
that it is an essential gene in this taxonomic group (9). The ZBED6–
Igf2 interaction also appears to be essential. This is based on the fact
that the 16 bp, which include the ZBED6 binding site in an intronic
region of Igf2, are highly conserved among placental mammals (8).
The present study shows that the Zbed6 knock-out mice develop
normally and show no obvious pathological conditions. However,
we show the ZBED6–Igf2 axis plays an essential role in regulating
postnatal growth of muscles and internal organs; findings that
provide a reasonable explanation for the high sequence conserva-
tion of ZBED6 and its binding site in the Igf2 gene. Thus, the
evolution of ZBED6 in placental mammals has added another layer
of regulation on the action of the highly potent growth factor IGF2.
The observed effects of Zbed6 knock-out and Igf2 knock-in on
Igf2 expression and serum IGF2 concentrations, as well as on
muscle and organ growth, were very similar, and there was no clear
additive effect of combining the two mutations. This strongly sug-
gests that ZBED6 is regulating muscle and organ growth through
its interaction with Igf2. Does this mean that the main functional
role of ZBED6 is to regulate Igf2 expression? This is probably not
the case, because we also show that Zbed6 inactivation and dis-
ruption of the ZBED6 binding site in Igf2 only led to partially
overlapping changes in the transcriptome (Fig. 5C). We identified
a number of putative direct ZBED6 targets that showed differen-
tial expression in the Zbed6 knock-out mice, but not in Igf2 knock-
in mice (e.g., Fig. 6E). Because ZBED6 has a very broad tissue
distribution and is expressed during different developmental stages,
it is plausible that Zbed6 inactivation is causing additional pheno-
typic effects on traits that were not measured in the current study.
The identification of increased muscle and organ growth was
guided by our previous discovery that disruption of the ZBED6
binding site in IGF2 is the causal mutation for a major QTL affecting
muscle and heart growth in pigs (8).
Zbed6 inactivation and the Igf2 knock-in mutation both resulted
in dramatic changes in Igf2 expression (up to 100-fold higher ex-
pression) compared with the rather modest phenotypic changes.
Therefore, an interesting topic for future research will be to ex-
plore how the complex physiological regulation of IGF2 signaling
may hamper the consequences of the dramatic up-regulation of
IGF2 expression in muscle, kidney, and other tissues. IGF2 sig-
naling is regulated by the IGF binding proteins that sequester
IGF2 in circulation, the IGF2 receptor (IGF2R) that reduces the
bioactivity of IGF2 (16), and regulation of the insulin receptor and
IGF1 receptor that can both be activated by IGF2 (17). The Igf2
locus also has a complex transcriptional regulation involving sev-
eral regulatory factors such as CTCF that maintains the imprinted
expression pattern of Igf2 and H19 (18, 19). This study adds to the
characterization of transcriptional regulation at the Igf2 locus and
shows that the expression of several forms of the Igf2 transcript,
including the opposite-strand (Igf2os) transcript, are affected by the
interaction with ZBED6. In contrast, the ZBED6–Igf2 interaction
does not appear to have a significant effect on transcriptional
regulation of the neighboring H19 gene.
In sharp contrast to the dramatic up-regulation in adult tis-
sues, only a modest effect of Zbed6 silencing on Igf2 expression
was noted in fetal tissues. This result is in perfect agreement with
our previous characterization of IGF2 mRNA expression in fetal
and adult tissues in pigs carrying the point mutation disrupting
the ZBED6 site in IGF2 (8). The minor effect in fetal tissues is
unlikely to be a result of a lack of ZBED6 expression, as Zbed6
mRNA levels were similar in adult and fetal tissue. Furthermore,
RNA-seq data from fetal tissue indicated that ZBED6 represses
the expression of other putative direct ZBED6 targets such as
Enho and Tmem8 previously identified by ChIP-seq analysis (9,
10). A more plausible explanation for the modest effect of Zbed6
silencing on Igf2 expression is epigenetic regulation, as gel shift
assays indicated that ZBED6 does not bind its target sequence
(GGCTCpG) when it is methylated (8).
The phenotypic consequences of Zbed6 inactivation and the
Igf2 regulatory mutation in transgenic mice showed both striking
similarities and differences compared with domestic pigs carrying
the IGF2 mutation (8). There was an excellent agreement be-
tween transgenic mice and mutant pigs regarding the minor role
for ZBED6 in the regulation of Igf2 expression in fetal tissues in
contrast to the major role in postnatal tissue. In addition, the
increased muscle growth is consistent with the pig phenotype, but
the increased muscle growth in female transgenic mice (+15–
20% increase) was more pronounced than in pigs (+4%). A
possible explanation for this difference is that the relative effect
of the IGF2 mutation in pigs is reduced because of the long
history of selection for increased muscle growth in pigs. This
selective breeding will have affected many genes in the genome,
although IGF2 was by far the most important locus explaining
differences in muscle growth in an intercross between the Eu-
ropean wild boar and Large White domestic pigs (20). However,
the marked sex difference in mice, including a more pronounced
effect on muscle growth in females than in males, is not observed
in pigs. A possible explanation for this species difference is that
most pigs used for meat production are castrated. Thus, the
phenotypic consequences of the up-regulated expression of Igf2
in male transgenic mice may have been masked by the action of
testosterone. This interpretation is supported by the fact that the
up-regulation of both Igf2 expression and serum IGF2 levels
were as dramatic in male as in female mice. The up-regulation of
Igf2 expression in mice (about 30-fold) was much larger than in
mutant pigs (about threefold). Both mutant pigs and transgenic
mice had a larger heart than wild-type animals. In contrast, the
weights of both liver and kidney were larger in transgenic mice
than in wild-type littermates, whereas no significant effect on the
weight of kidney or liver was observed in pigs, despite the fact
that the number of individuals in the pig experiment was an
order of magnitude higher than in the current mouse study (20).
Another striking difference was that the pig mutation did not
affect serum IGF2 concentrations (8) whereas transgenic mice
had about eightfold higher IGF2 concentration. A plausible ex-
planation for this is the corresponding striking difference in the
effects on IGF2 mRNA expression in liver in pigs and transgenic
mice, as liver is the major source of circulating IGF2. This could
also explain why transgenic mice showed a significant general
effect on growth, whereas mutant pigs showed normal body weight
but altered body composition. The elevated serum IGF2 concen-
trations in our transgenic mice imply that disturbed ZBED6–IGF2
interaction could be an explanation for elevated IGF2 serum con-
centrations in some human patients.
Taken together, this study demonstrates the important role of
the ZBED6–Igf2 axis in regulating Igf2 expression, muscle
growth, and the growth of internal organs in placental mammals.
The study has also established two unique mouse models for
further characterization of the functional importance of ZBED6
and the phenotypic consequences of a very specific up-regulation
of Igf2 expression. For instance, up-regulated expression of IGF2
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occurs in many cancers and is associated with poor prognosis
(17). The Igf2 knock-in mouse with its dramatic up-regulation of
Igf2 expression can now be exploited to study how IGF2 affects
origin, growth and cancer progression.
Materials and Methods
Animal Models. The Zbed6−/− and Igf2pA/mG models were both generated by
homologous recombination in mouse C57BL/6 ES cells. The targeted Zbed6
locus included a Neomycin (Neo) selection cassette flanked by FRT sites and
two loxP sites flanking the single Zbed6 exon. Neo was removed by mating
the mice with a strain expressing FlpE in germ line, leaving the flanking loxP
sites and a single FRT site within the region flanked by loxP sites (Fig. 1A).
These mice were in turn mated with PGK-Cre mice (21) expressing the Cre
recombinase in the germ line, resulting in the removal of the entire Zbed6
coding sequence, leaving only a single loxP site in a nonconserved region in
this intronic region (Fig. 1A).
Gene targeting at the Igf2 locus introduced the single G-A base change at
the ZBED6 binding site in the CpG island in an intronic region of Igf2 to-
gether with two loxP sites flanking the CpG island and a Neo cassette
flanked by FRT sites. Neo was removed by mating the mice with a line
expressing the FlpE recombinase in the germ line, resulting in the allele used
in the current study (Fig. 1B). The loxP sites flanking the CpG island were
introduced to make it possible to delete the entire CpG island to explore
whether it has any functions other than harboring a ZBED6 binding site.
The two transgenic mouse models were both maintained on a C57BL/6
background. Phenotypic characterization was carried out using littermates
segregating for the four genotype classes of major interest. The growth curve
was generated by measuring body weight starting from 6 wk until 20 wk of
age. Littermates of both males and females were used in all presented ex-
periments, and the wild-type animals were used as control. Total lean and fat
mass were assessed in conscious mice (23 wk of age), using the EchoMRI-
100 system (EchoMRI LLC). Tissue samples collected from 4-h fasted Avertin-
anesthetized mice; 16 μL/g body weight 2.5% avertin (2,2,2-tribromo ethanol
and tertiary amyl alcohol) were used for this purpose.
All animals were group-housed with free access to food and water in the
pathogen-free facilities of Uppsala University and Karolinska Institutet. All pro-
cedures described in this study were approved by the Uppsala Ethical Committee
onAnimal Research (#C63/15 and #C143/15) and the Stockholm Ethical Committee
(#N38/15), following the rules and regulations of the Swedish Animal Welfare
Agency, and were in compliance with the European Communities Council Di-
rective of 22 September 2010 (2010/63/EU). All efforts were made to minimize
animal suffering and to reduce the number of animals used.
Serum Concentration of IGF2. Concentrations of IGF2 was determined in mouse
serum, using a time-resolved immunofluorometric assay (TR-IFMA). Before assay,
50 μL mouse serum was added to 450 μL acetic acid (200 mM) with 0.05%
(vol/vol) HSA, 0.5% (vol/vol) Tween20, 0.9% (wt/vol) NaCl, reducing pH to
2.66 and hereby dissociating IGF2 from the IGF binding proteins (IGFBPs). The
IGFBPs were saturated with molar excess of IGF1 (100 ng/mL; GF-050–8; Austral
Biologicals) and incubated for 2 h at 5 °C. Samples were neutralized by the
addition of 500 μL Tris buffer [1.8% (wt/vol) Tris·HCL, 3.5% (wt/vol) Tris base]
with 1% (vol/vol) EDTA, 0.5% HSA, 0.2% Tween20, 0.9% NaCl. Thus, in the final
solution, mouse serumwas diluted 1:20. Recombinant mouse IGF2 (792-MG-050;
RnD Systems) served as calibrator and was subjected to the same procedures.
IGF2 concentrations were determined in triplicates using antibodies from a
commercial assay (DY792; RnD Systems). Biotinylated detection antibody was
diluted in assay buffer [PBS at pH 8.0, 0.05% (wt/vol) NaN3, 0.5% HSA, 0.5%
Tween20, 0.9% NaCl], mixed 1:1,000 with streptavidin-europium (PerkinElmer)
and determined as a TR-IFMA. Calibrators were prepared at final concentra-
tions ranging from 0 to 1 ng/mL, and the calibration curve behaved linearly
within this range. There was no cross-reactivity with mouse IGF1 (tested at
100 ng/mL). Intra-assay and interassay coefficients of variation (CVs) were <10%
and limit of detection was 0.05 ng/mL Because of limited sample material,
measurements were not obtained from one female Zbed6−/− mouse. All other
sample measurements were above limit of detection.
RNA Sequencing. Tissues were placed in RNAlater (Sigma) directly after col-
lection. RNA extraction was performed using the RNeasy Mini kit (QIAGEN).
The RNA quality and integrity were measured with a RNA ScreenTape assay
(TapeStation; Agilent Technologies). Strand-specific mRNA sequencing li-
braries from five individuals per genotype were generated using the SENSE
RNA-Seq Library Prep Kit (Lexogen) following the manufacturer’s instruc-
tions. The libraries were sequenced as 125-bp single reads, using an Illumina
HiSeq instrument. Sequenced reads were mapped to the reference mouse
genome (mm10) using STAR with default parameters (22). Cufflinks and
Cuffdiff were used as described by Trapnell et al. (23) to identify differentially
expressed genes and isoforms based on gene models for mm10 downloaded
from the UCSC Genome Browser (https://genome.ucsc.edu/), and the abun-
dance of gene expression was calculated as fragment per kilobase of tran-
script per million mapped reads (FPKM). The cummerbund R package was
used for gene expression data visualization (23). The mapped reads were vi-
sualized using the integrative genomics viewer (24).
Quantitative PCR. Total RNA was extracted using the RNeasy Mini kit (Qiagen),
and the samples were treatedwith DNase I to eliminate genomic DNA. The High
Capacity cDNA Reverse Transcription Kit (Applied Biosystems) was used to
generate cDNA from RNA. qPCR analysis was performed in ABI MicroAmp
Optical 384-well Reaction plates on an ABI 7900 real-time PCR instrument, using
TaqMan gene expression reagents (Applied Biosystems). The amplification and
detection of each gene was performed using TaqMan Gene Expression Assays
that consisted of forward and reverse primerswith TaqManminor groove binder
probe for each gene (Zbed6: Mm04178798_s1; Igf2: Mm00439564_m1; Tbp:
Mm01277042_m1; Enho: Mm01223541_m1; 18S: Mm03928990_g1; Applied
Biosystems); 18S and Tbp were used as housekeeping genes.
Glucose Tolerance Test. Mice (24 wk of age) were fasted for 4 h and injected
intraperitoneally with 2 g/kg glucose. Blood glucose was measured 0, 15, 30,
60, and 120 min after injection (OneTouch Ultra 2 glucose meter; LifeScan).
Plasma insulin concentration was measured at 0 and 15 min, using an ELISA
with mouse insulin as standard (Crystal Chem).
Metabolic Cages. Mice (24–26 wk of age) were acclimated for 24 h in single
cages. Subsequently, mice were monitored for 2 d in the TSE PhenoMaster
home cage system (TSE Systems) in a controlled environment (12 h light/12 h
dark, 25 °C, 45% humidity) with ad libitum access to standard rodent chow
(R34; Lantmännen) and water. The RER was calculated from the continu-
ously measured O2 consumption (V̇o2) and CO2 production (V̇co2).
Statistical Analysis. The sample sizes for phenotypic characterization were 5–
10 per male genotype and 5–11 per female genotype, and five per group for
gene expression analysis. Data are presented as mean ± SEM. Values were
analyzed by two-tailed unpaired Student’s t tests, one-way analysis of vari-
ance followed by Tukey’s post hoc test, or two-way analysis of variance
followed by Sidak’s test for multiple comparisons, using GraphPad Prism
version 6. P < 0.05 was considered statistically significant.
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